Association study of three single‑nucleotide polymorphisms in the cyclic adenosine monophosphate response element binding 1 gene and major depressive disorder

Wei,Yange; Bu,Shufang; Liu,Xican; Li,Hengfen

doi:10.3892/etm.2015.2408

Association study of three single‑nucleotide polymorphisms in the cyclic adenosine monophosphate response element binding 1 gene and major depressive disorder

Authors:
- Yange Wei
- Shufang Bu
- Xican Liu
- Hengfen Li
View Affiliations

Affiliations: Department of Psychiatry, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Geriatric Neurology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, P.R. China
Published online on: April 3, 2015 https://doi.org/10.3892/etm.2015.2408
Pages: 2235-2240

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Major depressive disorder is a common chronic emotional disorder, and cyclic adenosine monophosphate response element binding protein 1 (CREB1) is hypothesized to play a role in its pathogenesis. The aim of the present study was to investigate the associations between major depressive disorder and relevant single nucleotide polymorphisms (SNPs) in the CREB1 gene. A total of 1,038 subjects of Han Chinese descent were recruited, including 456 patients with major depressive disorder (case group) and 582 healthy volunteers (control group). The frequency distributions of the genotypes and alleles were estimated in the case and control groups, and analyzed for any correlation with major depressive disorder. Three relevant SNP sites in CREB1 were analyzed using quantitative polymerase chain reaction, and statistical analyses were performed to estimate their use as risk factors for major depressive disorder. The analyses revealed that rs2254137 and rs16839883 in CREB1 showed polymorphisms in the sample population, and the genotype and allele frequencies of rs16839883 differed significantly when comparing the patients and healthy controls (P<0.05). No statistically significant differences were detected in the two SNP sites between the male and female patients (P>0.05). Furthermore, no statistically significant differences were detected in rs2254137 genotype and allele distribution when comparing the male and female patients with their corresponding control groups (P>0.05). However, statistically significant differences were observed in the genotype and allele frequencies of rs16839883 when the male and female patients were compared with their respective controls (P<0.05). Therefore, the results demonstrated that there is a close correlation between the rs16839883 polymorphism in CREB1 and major depressive disorder, which suggests that this SNP site should be further studied as a potential biomarker for major depressive disorder.

View Figures

View References

1	Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 367:1747–1757. 2006. View Article : Google Scholar : PubMed/NCBI
2	Spiessl H, Hübner-Liebermann B and Hajak G: Depression, a widespread disease. Epidemiology, care situation, diagnosis, therapy and prevention. Dtsch Med Wochenschr. 131:35–40. 2006.[(In German)]. PubMed/NCBI
3	Mamdani F, Alda M, Grof P, Young LT, Rouleau G and Turecki G: Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet. 147B:500–504. 2008. View Article : Google Scholar : PubMed/NCBI
4	Risch N, Herrell R, Lehner T, et al: Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA. 301:2462–2471. 2009. View Article : Google Scholar : PubMed/NCBI
5	Kendler KS, Gatz M, Gardner CO and Pedersen NL: Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry. 63:1113–1120. 2006. View Article : Google Scholar : PubMed/NCBI
6	Terracciano A, Tanaka T, Sutin AR, et al: Genome-wide association scan of trait depression. Biol Psychiatry. 68:811–817. 2010. View Article : Google Scholar : PubMed/NCBI
7	Cryan JF and Mombereau C: In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry. 9:326–357. 2004. View Article : Google Scholar : PubMed/NCBI
8	Gaspar L, van de Werken M, Johansson AS, Moriggi E, Owe-Larsson B, Kocks JW, Lundkvist GB, Gordijn MC and Brown SA: Human cellular differences in cAMP—CREB signaling correlate with light-dependent melatonin suppression and bipolar disorder. Eur J Neurosci. 40:2206–2215. 2014. View Article : Google Scholar : PubMed/NCBI
9	Meyer J, Wiedemann P, Okladnova O, et al: Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm. 105:1341–1350. 1998. View Article : Google Scholar : PubMed/NCBI
10	Zhang HT, Whisler LR, Huang Y, Xiang Y and ODonnell JM: Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. Neuropsychopharmacology. 34:1067–1077. 2009. View Article : Google Scholar : PubMed/NCBI
11	Hu YF, Caron MG and Sieber-Blum M: Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis. BMC Genomics. 10:1512009. View Article : Google Scholar : PubMed/NCBI
12	Brummett BH, Babyak MA, Williams RB, Harris KM, Jiang R, Kraus WE, Singh A, Costa PT, Georgiades A and Siegler IC: A Putatively Functional Polymorphism in the HTR2C Gene is Associated with Depressive Symptoms in White Females Reporting Significant Life Stress. PLoS One. 9:e1144512014. View Article : Google Scholar : PubMed/NCBI
13	Fabbri C, Souery D, Calati R, et al: Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients. J Neural Transm. 122:43–58. 2015. View Article : Google Scholar : PubMed/NCBI
14	Li M, Luo XJ, Rietschel M, et al: Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Mol Psychiatry. 19:452–461. 2014. View Article : Google Scholar : PubMed/NCBI
15	Calati R, Crisafulli C, Balestri M, et al: Evaluation of the role of MAPK1 and CREB1polymorphisms on treatment resistance, response and remission in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 1. 44:271–278. 2013. View Article : Google Scholar
16	Bae JS, Kim JY, Park BL, et al: Investigating the potential genetic association between RANBP9 polymorphisms and the risk ofschizophrenia. Mol Med Rep Dec. 4:2014.(Epub ahead of print).
17	Zhong X, Zhang L, Han S, An Z and Yi Q: Case control study of association between the ANK3 rs10761482 polymorphism and schizophrenia in persons of Uyghur nationality living in Xinjiang China. Shanghai Arch Psychiatry. 26:288–293. 2003.
18	Jitoku D, Yamamoto N, Iwayama Y, et al: Association study of H2AFZ with schizophrenia in a Japanese case-control sample. J Neural Transm. Nov 13–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
19	Oelke M, Hedlund P, Albrecht K, et al: Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology. 67:1111–1116. 2006. View Article : Google Scholar : PubMed/NCBI
20	Liu XH: Preliminary study on the genetic effects and genetic mode of first-episode depression, as well as association and expression study of CREB1, BDNF gene in major depression. Unpublished PhD thesisFudan University Shanghai: 2006, [(In Chinese)].
21	Liu XH, Xu YF, Cui DH, et al: Association of cyclic adenosine monophosphate response element-binding protein gene and major depressive disorder. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 27:263–266. 2010.[(In Chinese)]. PubMed/NCBI
22	Turner CA, Thompson RC, Bunney WE, et al: Altered choroid plexus gene expression in major depressive disorder. Front Hum Neurosci. 8:2382014. View Article : Google Scholar : PubMed/NCBI
23	Li M, Luo XJ, Rietschel M, et al: MooDS Bipolar Consortium, Swedish Bipolar Study Group, Alzheimers Disease Neuroimaging Initiative, ENIGMA Consortium and CHARGE Consortium: Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Mol Psychiatry. 19:452–461. 2014. View Article : Google Scholar : PubMed/NCBI
24	Lipina TV, Fletcher PJ, Lee FH, Wong AH and Roder JC: Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. Neuropsychopharmacology. 38:423–436. 2013. View Article : Google Scholar : PubMed/NCBI
25	Wang H, Zhang Y and Qiao M: Mechanisms of extracellular signal-regulated kinase/cAMP response element-binding protein/brain-derived neurotrophic factor signal transduction pathway in depressive disorder. Neural Regen Res. 8:843–852. 2013.PubMed/NCBI
26	Serretti A, Chiesa A, Calati R, et al: A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. J Affect Disord. 128:56–63. 2011. View Article : Google Scholar : PubMed/NCBI
27	Burcescu I, Wigg K, King N, et al: Association study of CREB1 and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet. 137B:45–50. 2005. View Article : Google Scholar : PubMed/NCBI
28	Calati R, Crisafulli C, Balestri M, et al: Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 44:271–278. 2013. View Article : Google Scholar : PubMed/NCBI
29	Martini C, Da Pozzo E, Carmassi C, et al: Cyclic adenosine monophosphate responsive element binding protein in post-traumatic stress disorder. World J Biol Psychiatry. 14:396–402. 2013. View Article : Google Scholar : PubMed/NCBI
30	Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS and Young LTG: Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem. 73:1121–1126. 1999. View Article : Google Scholar : PubMed/NCBI
31	Yamada S, Yamamoto M, Ozawa H, Riederer P and Saito T: Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm. 110:671–680. 2003. View Article : Google Scholar : PubMed/NCBI
32	Koch JM, Hinze-Selch D, Stingele K, et al: Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression. Psychother Psychosom. 78:187–192. 2009. View Article : Google Scholar : PubMed/NCBI
33	Blendy JA: The role of CREB in depression and antidepressant treatment. Biol Psychiatry. 59:1144–1150. 2006. View Article : Google Scholar : PubMed/NCBI
34	Qi X, Lin W, Li J, Li H, Wang W, Wang D and Sun M: Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol Dis. 31:278–285. 2008. View Article : Google Scholar : PubMed/NCBI